A large international study has found that asundexian, an investigational anti-clotting medication, reduces the risk of a stroke in people who recently experienced a stroke or transient ischemic ...
DMPA denotes depot medroxyprogesterone acetate, GAHT gender-affirming hormone therapy, GnRH gonadotropin-releasing hormone, HRT hormone-replacement therapy, and MPA medroxyprogesterone acetate.
All that most laymen know about hemophilia is that it is an odd and dangerous disease of the blood that strikes men only, although it is transmitted by women. Medical researchers have learned a great ...
With a $157 million series C funding round, Hemab Therapeutics is looking to infuse innovation into the treatment landscape for rare and underserved bleeding disorders. The oversubscribed series C was ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Major new analysis from the Thrombotic Thrombocytopenia Syndrome (TTS) Consortium has provided critical insights into the rare but serious condition known as vaccine-induced immune thrombotic ...
Genetic research in Sweden has unveiled three new gene variants that dramatically increase the risk of venous blood clots, sometimes by up to 180%. These discoveries build on existing knowledge of ...
Few bodily functions are as misunderstood as blood clots. While most people have heard about blood clots in the heart or brain causing serious issues or even death, fewer realize that blood clotting ...
Kenichi Tanaka, M.D., is a professor and chair of the Department of Anesthesiology at the University of Oklahoma College of Medicine. The research, presented this weekend at the annual meeting of the ...
Hemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII. Treatment focuses on managing bleeding episode symptoms with clotting factor replacement therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results